CVD EQUIPMENT CORP quarterly report, Q3 FY2017

CVD Equipment Corporation — Form 10-Q Summary

Reporting period: Quarter and nine months ended September 30, 2017. CVD Equipment designs and manufactures process equipment and operates its CVD and SDC divisions. Financial statements are unaudited.

Financial performance and position

MetricQ3 2017Q3 2016Nine months 2017Nine months 2016
Revenue$10.83 million$4.88 million$31.31 million$13.63 million
Gross profit / margin$4.60 million / 42.5%$1.69 million / 34.6%$13.18 million / 42.1%$3.72 million / 27.3%
Operating income (loss)$1.89 million$(0.40) million$5.44 million$(1.91) million
Net income (loss)$1.40 million$(0.09) million$3.68 million$(0.92) million
Diluted earnings (loss) per share$0.22$(0.01)$0.58$(0.15)
  • For the nine months, operating cash flow was negative $3.67 million, compared with positive $3.17 million a year earlier. Cash and cash equivalents fell $4.50 million to $17.18 million; capital expenditures were $0.62 million.
  • Working capital was $24.8 million at September 30, versus $19.9 million at December 31, 2016. Accounts receivable increased to $4.06 million from $0.61 million, while costs and estimated earnings in excess of billings rose to $4.46 million.
  • Total debt was approximately $3.04 million, including $0.30 million current. The company had an unused $7 million revolving credit facility available through September 1, 2018, subject to covenants, which it was meeting. The mortgage loan is due in 2022.
  • At September 30, total assets were $45.80 million and stockholders’ equity was $38.69 million.

Changes versus prior comparable periods

  • Revenue rose 121.8% in Q3 and 129.7% for the nine months, primarily reflecting work on orders received over the preceding 15 months. Both divisions grew; CVD generated most revenue.
  • Gross margins improved substantially, which management attributed to higher revenue and product mix. Results moved from operating and net losses to profits in both comparison periods.
  • Operating expenses increased, including general and administrative costs, partly due to personnel and occupancy costs related to CVD Materials and its CVD Tantaline ApS subsidiary.
  • The 2016 nine-month comparison included a $629,000 gain from a negotiated reduction in legal fees related to the Taiwan Glass litigation. The 2016 quarter also included approximately $119,000 of insurance proceeds in excess of property repair costs.

Outlook, risks and notable items

  • Management said cash and expected operating cash flow should meet working-capital and capital-expenditure needs for the next 12 months. No specific revenue or earnings guidance was provided.
  • Customer concentration is significant: one customer accounted for approximately 59% of Q3 revenue and 65% of nine-month revenue. Three customers represented 23.2%, 14.2% and 10.0% of period-end receivables. Management cautioned that reductions, delays or cancellations by major customers could materially affect results.
  • Cash and investments exceeded FDIC insurance limits by $15.6 million at September 30. Contract revenue is recognized in part using percentage-of-completion estimates; changes in costs, requirements or estimated profitability may affect reported results.
  • Subsequent event: on October 24, the company agreed to buy Central Islip property for $13.85 million, with closing anticipated around January 22, 2018. The purchase is contingent, among other conditions, on a $10.3875 million first-mortgage commitment. The $500,000 escrow deposit had been paid by the filing date.
  • On October 31, a wholly owned indirect subsidiary acquired substantially all operating assets and the business of MesoScribe Technologies for $800,000: $500,000 paid at closing and up to $300,000 in contingent consideration based on specified revenue and other criteria.
  • The company was still evaluating the operational and accounting effects of the new revenue-recognition standard, ASC 606. Management identified competition, access to acceptable financing, and uncertainty about future profitability and expansion among forward-looking risks.

Investor verification points

  • Assess whether the sharp revenue growth and improved margins can continue, particularly given reliance on one customer and changing order mix.
  • Review receivable collection, contract asset movements and operating cash conversion, which was negative despite reported nine-month earnings.
  • Verify financing, closing conditions and funding impact of the $13.85 million property purchase, alongside the MesoScribe acquisition and contingent payments.
  • Check the company’s progress and disclosed effects from adopting ASC 606, and monitor mortgage and revolving-facility terms and covenant compliance.